These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8673997)

  • 61. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
    Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
    Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
    Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease].
    Wu S; Liew CT; Li X
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):91-3. PubMed ID: 11244969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
    Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
    Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
    Wee A; Nilsson B
    Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Fatal complication of fine-needle biopsy of the liver].
    Weiss H; Weiss A; Schöll A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):139-42. PubMed ID: 2827984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
    Yao DF; Wu W; Yao M; Qiu LW; Wu XH; Su XQ; Zou L; Yao DB; Meng XY
    World J Gastroenterol; 2006 Aug; 12(31):4966-72. PubMed ID: 16937491
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis.
    Le Faouder J; Laouirem S; Chapelle M; Albuquerque M; Belghiti J; Degos F; Paradis V; Camadro JM; Bedossa P
    J Proteome Res; 2011 Aug; 10(8):3755-65. PubMed ID: 21675781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
    Kanamaru T; Morita Y; Itoh T; Yamamoto M; Kuroda Y; Hisatomi H
    Jpn J Cancer Res; 1998 Jul; 89(7):727-32. PubMed ID: 9738979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Telomerase activity as a novel marker of lung cancer].
    Hiyama K; Ishioka S; Hiyama E; Yamakido M
    Nihon Rinsho; 1998 May; 56(5):1253-7. PubMed ID: 9613133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histopathology of hepatocellular carcinoma.
    Paradis V
    Recent Results Cancer Res; 2013; 190():21-32. PubMed ID: 22941011
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
    Ohta K; Kanamaru T; Morita Y; Hayashi Y; Ito H; Yamamoto M
    J Gastroenterol; 1997 Dec; 32(6):791-6. PubMed ID: 9430018
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytodiagnosis of hepatocellular carcinoma in fine-needle aspirates of the liver: its differentiation from reactive hepatocytes and metastatic adenocarcinoma.
    Das DK
    Diagn Cytopathol; 1999 Dec; 21(6):370-7. PubMed ID: 10572267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cell features and patterns in fine-needle aspirates of hepatocellular carcinoma.
    Noguchi S; Yamamoto R; Tatsuta M; Kasugai H; Okuda S; Wada A; Tamura H
    Cancer; 1986 Jul; 58(2):321-8. PubMed ID: 3013389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Telomerase activity in association with the pathological differentiation of prostate cancer].
    Uemura H; Lin Y; Kubota Y
    Nihon Rinsho; 1998 May; 56(5):1287-91. PubMed ID: 9613139
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .
    Giannitrapani L; Ingrao S; Soresi M; Florena AM; La Spada E; Sandonato L; D'Alessandro N; Cervello M; Montalto G
    Ann N Y Acad Sci; 2009 Feb; 1155():293-9. PubMed ID: 19250220
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of morphometry in the cytology of well-differentiated hepatocarcinoma and cirrhosis with atypia.
    Zeppa P; Zabatta A; Fulciniti F; Vetrani A; Di Benedetto G; De Rosa G; Palombini L
    Anal Quant Cytol Histol; 1988 Oct; 10(5):343-8. PubMed ID: 2849953
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
    Li CP; Huang TS; Chao Y; Chang FY; Whang-Peng J; Lee SD
    World J Gastroenterol; 2004 Sep; 10(17):2468-71. PubMed ID: 15300886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma.
    Nguyen T; Phillips D; Jain D; Torbenson M; Wu TT; Yeh MM; Kakar S
    Arch Pathol Lab Med; 2015 Aug; 139(8):1028-34. PubMed ID: 26230595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Significant correlation of telomerase activity in lung adenocarcinomas with cell differentiation and chromosome aberration].
    Fujiwara M; Okayasu I; Takemura T; Oshimura M
    Nihon Rinsho; 1998 May; 56(5):1258-63. PubMed ID: 9613134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.